Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to Vδ1 Gamma-Delta T-Cell-Mediated Killing

Endometriosis-Associated Macrophages: Origin, Phenotype, and Function

(2020) Chloe Hogg et al.   Frontiers in Endocrinology

Human γδ TCR Repertoires in Health and Disease

(2020) Alina Suzann Fichtner et al.   Cells

Deciphering human γδ T cell response in cancer: Lessons from tumor‐infiltrating γδ T cells

(2020) Elena Lo Presti et al.   IMMUNOLOGICAL REVIEWS

Targeting EphA2 in cancer

(2020) Ta Xiao et al.   Journal of Hematology & Oncology

Endometrial Cancer

(2020) Karen H. Lu et al.   NEW ENGLAND JOURNAL OF MEDICINE

γδ cell-based immunotherapy for cancer

(2019) Elena Lo Presti et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

The endometrial immune environment of women with endometriosis

(2019) Júlia Vallvé-Juanico et al.   HUMAN REPRODUCTION UPDATE

Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies

(2019) Zsolt Sebestyen et al.   NATURE REVIEWS DRUG DISCOVERY

IL‐10 from plasmacytoid dendritic cells promotes angiogenesis in the early stage of endometriosis

(2019) Jau‐Ling Suen et al.   JOURNAL OF PATHOLOGY

Involvement of immune cells in the pathogenesis of endometriosis

(2018) Gentaro Izumi et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer

(2016) Katherine R. Amato et al.   CANCER RESEARCH

Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis

(2016) Sun-Wei Guo et al.   HUMAN REPRODUCTION

World Endometriosis Society consensus on the classification of endometriosis

(2016) Neil P. Johnson et al.   HUMAN REPRODUCTION

Decreased Cytotoxicity of Peripheral and Peritoneal Natural Killer Cell in Endometriosis

(2016) InCheul Jeung et al.   Biomed Research International

Estradiol Is a Critical Mediator of Macrophage-Nerve Cross Talk in Peritoneal Endometriosis

(2015) Erin Greaves et al.   AMERICAN JOURNAL OF PATHOLOGY

Natural Killer Cells: Key Players in Endometriosis

(2015) Uma Thiruchelvam et al.   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY

IL-17A Contributes to the Pathogenesis of Endometriosis by Triggering Proinflammatory Cytokines and Angiogenic Growth Factors

(2015) Soo Hyun Ahn et al.   JOURNAL OF IMMUNOLOGY

The prognostic landscape of genes and infiltrating immune cells across human cancers

(2015) Andrew J Gentles et al.   NATURE MEDICINE

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia

(2015) Sara Charmsaz et al.   PLoS One

γδT Cells: First Line of Defense and Beyond

(2014) Yueh-hsiu Chien et al.   Annual Review of Immunology

An increased level of IL-6 suppresses NK cell activity in peritoneal fluid of patients with endometriosis via regulation of SHP-2 expression

(2014) Young-Ju Kang et al.   HUMAN REPRODUCTION

Clinical Applications of Gamma Delta T Cells with Multivalent Immunity

(2014) Drew C. Deniger et al.   Frontiers in Immunology

Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells

(2012) Andrea Knight et al.   CYTOTHERAPY

Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer

(2011) William M. Merritt et al.   CANCER BIOLOGY & THERAPY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Immune interactions in endometriosis

(2011) Jennifer L Herington et al.   Expert Review of Clinical Immunology

Targeting Eph receptors with peptides and small molecules: Progress and challenges

(2011) Roberta Noberini et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma

(2010) J. W. Lee et al.   CLINICAL CANCER RESEARCH

Emerging strategies for EphA2 receptor targeting for cancer therapeutics

(2010) Manish Tandon et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Endometriosis

(2010) Linda C. Giudice   NEW ENGLAND JOURNAL OF MEDICINE

EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer

(2009) Aparna A. Kamat et al.   CANCER

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

(2009) M. A. Cheever et al.   CLINICAL CANCER RESEARCH

The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting

(2008) J. Wykosky et al.   MOLECULAR CANCER RESEARCH